ORASURE TECHNOLOGIES INC. - COMMON STOCK

OraSure Technologies Continues its Dedication to Ending the HIV Epidemic

01 Dec 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at Stephens Annual Investment Conference

14 Nov 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

08 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

03 Nov 2022 09:15:00 By Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store

02 Nov 2022 07:05:00 By Nasdaq GlobeNewswire

2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET

01 Nov 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

28 Sep 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention

20 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health

14 Sep 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

09 Aug 2022 16:05:02 By Nasdaq GlobeNewswire

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

02 Aug 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

28 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

14 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing

25 May 2022 07:05:00 By Nasdaq GlobeNewswire

Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure

23 May 2022 16:05:00 By Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

17 May 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

10 May 2022 16:05:01 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET

03 May 2022 16:05:00 By Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

07 Apr 2022 07:05:00 By Nasdaq GlobeNewswire